丹尼尔·利维

Daniel Levy, M.D. is Chief of the Population Sciences Branch of the National Heart, Lung, and Blood Institute, Professor of Medicine, Boston University School of Medicine, and Senior Scientist with the Framingham Heart Study. His main areas of research interest include the epidemiology and genetics of hypertension, heart disease and heart failure. As one of the founders of an international genetics consortium, he has led genome-wide association studies that have identified most of the known genes associated with hypertension. He has received the National Institutes of Health Director’s Award three times for his research accomplishments. In November 2009 he was the recipient of the American Heart Association’s highest recognition for research achievements in epidemiology, the Population Research Prize. He was named by Clarivate Analytics (formerly Thomson Reuters) as one of the world’s “best and brightest scientific minds of our time” seven consecutive years. He has published over 800 articles in leading medical journals. He authored a book about the revolution in understanding of heart disease titled “A Change of Heart” (published by Alfred A. Knopf) and serves as Editor-in-Chief of the International Journal of Cardiology: Cardiovascular Risk and Prevention. He served with the National High Blood Pressure Education Program and the National Cholesterol Education Program in the formulation of national hypertension and cholesterol guidelines.